The market for implant, restorative, and regenerative dentistry, was valued at £3.2 billion (US$5.1bn) in 2011 by Millennium Research Group and iData. This is based on turnover, the majority of which is generated by the sales of Dental implants Boca RAton Fl and abutments. The market for dental implants alone in the principal global regions was estimated to be £2bn (US$3.2bn) in 2009.
Whilst filling a vital need for many patients, dental implants would be defined as somewhat of a luxury product in economic terms. This is evidenced by the market’s reaction to global economic events over the past 3 years. The global market for dental implants declined for the first time in 2009. The global recession meant consumers had less disposable cash. As belts were tightened, patients postponed treatments or turned to cheaper (yet inferior) and possibly government subsidised solutions. The implant dentistry market stabilised in 2010 growing at a slow single digit rate. In 2011, the market grew again in the low single-digit range as consumer fears and a weaker economy especially in Europe slowed growth. It is clear that demand for dental implants is quite reactive to the general economic climate.
In the first years of the global recession, demand was most affected in the North American market which shrank relative to other regions. However, for the past couple of years, the market structure has remained largely unchanged. Although, additional disposable cash in emerging countries and improvements in the standard of living has led to an increase in demand for aesthetic tooth restorations in these countries. Consequently, the share of the market in emerging markets has been edging up in recent years. Europe still makes up about half of the global market, North America is the second largest region driving about 50% of dental implant revenue and then this is followed by Asia/Pacific. Growth in the Asia/Pacific region is now being driven by China and is expected to increase the global size in coming years.
The five leading manufacturers are Straumann, Nobel Biocare, Dentsply, Biomet 3i and Zimmer Dental. They account for approximately 54% of the global market (see chart). In 2011, Dentsply acquired Astra Tech from Astra Zeneca, creating a new major force in the market. Dentsply is now the third biggest manufacturer of dental implants. Discount implants manufacturers, the most fragmented part of the market, are growing in market share as more and more dentists are switching to low cost alternatives in response to tough economic conditions.